These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2946224)

  • 1. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam.
    Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ
    Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males.
    Salom IL; Jacob G; Jallad N; Perdomo CA; Mullane JF; Weidler D
    J Clin Pharmacol; 1984; 24(5-6):240-6. PubMed ID: 6235249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL; Arnold JD
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the antiarthritic efficacy and safety of etodolac.
    Zvaifler N
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():43-53. PubMed ID: 2525982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etodolac, aspirin, and gastrointestinal microbleeding.
    Arnold JD; Mullane JF; Hayden DM; March L; Hart K; Perdomo CA; Fencik M; Berger AE
    Clin Pharmacol Ther; 1984 May; 35(5):716-21. PubMed ID: 6232035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etodolac. A preliminary review of its pharmacodynamic activity and therapeutic use.
    Lynch S; Brogden RN
    Drugs; 1986 Apr; 31(4):288-300. PubMed ID: 2940079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of etodolac administration on renal function in patients with arthritis.
    Shand DG; Epstein C; Kinberg-Calhoun J; Mullane JF; Sanda M
    J Clin Pharmacol; 1986 Apr; 26(4):269-74. PubMed ID: 2939116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAIDs and faecal blood loss in elderly patients with osteoarthritis: is plasma half-life relevant?
    Scharf S; Kwiatek R; Ugoni A; Christophidis N
    Aust N Z J Med; 1998 Aug; 28(4):436-9. PubMed ID: 9777110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee.
    Astorga Paulsen G; Baigun S; Galvao de Figueiredo J; Gomes de Freitas G
    Curr Med Res Opin; 1991; 12(6):401-12. PubMed ID: 1828415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of etodolac in the elderly population.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):19-22. PubMed ID: 7744124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global safety evaluation of etodolac.
    Karbowski A
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():73-9. PubMed ID: 2525986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.
    Lee D; Dvornik D
    Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis.
    Schattenkirchner M
    Curr Med Res Opin; 1991; 12(8):497-506. PubMed ID: 1837260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.
    Vetter G; Placchi M; Joubert L
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):240-5. PubMed ID: 6212555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
    Veys EM
    Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study.
    Illnait J; Terry H; Más R; Fernández L; Carbajal D
    J Med Food; 2005; 8(1):63-8. PubMed ID: 15857212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.